ZeroDay Findings
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2026-28167

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Super Forms allows Path Traversal.

Published Aug 24, 2026 · catalog updated Oct 14, 2026 · Improper Limitation of a

Check if you run it

No confirmed exploitation is on record for CVE-2026-28167. EPSS is 0.50%. Act only if a listed version of Improper Limitation of a is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (Improper Limitation of a).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High7.5
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.50%
Remediation
Advisory link
Affected products
See sources for product scope

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Super Forms allows Path Traversal. This issue affects Super Forms: from n/a through 6.3.316.

No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.

How to fix CVE-2026-28167

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-28167. EPSS is 0.50%. Act only if a listed version of Improper Limitation of a is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-22: Path Traversal. EPSS 0.50%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Aug 24, 2026 · NIST NVD

    Detected

    Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Super Forms allows Path Traversal. This issue affects Super Forms: from n/a through 6.3.316.

  2. Oct 14, 2026 · NIST NVD

    Updated

    Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Super Forms allows Path Traversal. This issue affects Super Forms: from n/a through 6.3.316.

Sources

  • CVE.orgVulnerability recordCVE-2026-28167

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-28167

    30-day exploitation probability 0.5%

    first.org
  • NIST NVDVulnerability recordCVE-2026-28167

    Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Super Forms allows Path Traversal. This issue affects Super Forms: from n/a through 6.3.316.

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.